China's Weigao H1 profit falls 23% as price drops, competition hit margins

Shandong Weigao Medical Polymer

25/08/2026 13:55

Overview
China medical device maker's H1 revenue rose 3.1% yr/yr, net profit fell 23.2%
Gross margin dropped 3.4 percentage points due to policy-driven price declines and competition
Board proposed lower interim dividend of RMB0.0854 per share, down from RMB0.0969 last year

Outlook
Company did not provide specific financial guidance or outlook for future periods

Result Drivers
PRICE PRESSURE - Co said gross margin fell due to lower selling prices for generic medical device, orthopaedic and flushing syringe products following policy changes
COMPETITION & PROCEDURE VOLUME - Co said orthopaedic segment revenue declined due to intensified market competition and fluctuations in clinical surgical procedure volumes
EXCHANGE RATE IMPACT - Co said interventional segment performance was hurt by significant negative impact of exchange rate gains or losses

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Revenue
 
RMB 6.85 bln
 
H1 Net Income Attributable
 
RMB 890.4 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Shandong Weigao Group Medical Polymer Co Ltd is HK$5.75, about 65.2% above its August 25 closing price of HK$3.48
The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 7 three months ago

Reuters Recommended Reads
Aug 24 - China's Shanghai INT Medical Instruments H1 revenue jumps on acquisitions
Aug 24 - China's Peijia Medical H1 revenue jumps on transcatheter valve therapeutics growth
Aug 24 - Sinopharm interim revenue edges down on softness in pharmaceutical distribution business

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Press Release s3://eap-prd-eu-west-1-source-content/eap_feed_proxy/fingerpost/HKSW/2026-08-25/81ce8e32-8f89-46bc-a799-e18218949a59.file
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)